Key facts
- Liminatus Pharma secured $1.9 million in cash.
- The funds were raised through the exercise of warrants.
- The company plans to use the funds for general corporate purposes.
Liminatus Pharma announced on Tuesday that it has secured $1.9 million in gross proceeds from the exercise of warrants. The company stated that the funds will be used for general corporate purposes. Further details regarding the specific warrants exercised or the parties involved were not immediately disclosed.